抗菌薬耐性サーベイランスの市場規模・シェア・成長分析 (コンポーネント別、技術別、エンドユーザー別、地域別)：産業予測 (2025～2032年)

世界の抗菌薬耐性サーベイランスの市場規模は、2023年に59億米ドルと評価され、2024年の62億3,000万米ドルから2032年には96億3,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.6％で成長する見通しです。

抗菌薬耐性の蔓延は、世界の健康上の大きな課題となっており、政府、保健機関、国際機関が強固なサーベイランスシステムに対する関心を高めています。薬剤耐性感染症の増加を受けて、迅速なデータ収集、病原体の追跡、耐性パターン評価の必要性が急増しており、迅速な検出と十分な情報に基づく臨床的選択を容易にする高度な抗菌薬耐性サーベイランス機能の需要が強調されています。公衆衛生の準備と感染管理に対するこのような関心の高まりが、市場の拡大に拍車をかけています。同時に、規制当局のイニシアチブと世界の行動枠組みが、サーベイランス能力の強化を促しています。各国はリアルタイム報告のための検査インフラや統合データシステムに投資し、調査効率を高めています。医療提供者は、これらのシステムを活用して感染管理を強化し、抗菌薬スチュワードシップを重視して医療関連感染を減らし、最終的に市場成長の加速を支えています。

目次

イントロダクション

• 分析目的
• 市場範囲
• 定義

分析手法

• 情報調達
• 二次・一次データの手法
• 市場規模予測
• 市場の想定と制約

エグゼクティブサマリー

• 市場の概要と展望
• 需給動向の分析
• セグメント別の機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析

市場の主な考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場魅力度指数 (2024年)
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ

世界の抗菌薬耐性サーベイランスの市場規模・CAGR：コンポーネント別 (2025～2032年)

• 市場概要
• ソフトウェア
• ハードウェア
• サービス

世界の抗菌薬耐性サーベイランスの市場規模・CAGR：技術別 (2025～2032年)

• 市場概要
• 表現型法
• 遺伝子型法
• バイオインフォマティクス・ソリューション

世界の抗菌薬耐性サーベイランスの市場規模・CAGR：エンドユーザー別 (2025～2032年)

• 市場概要
• 病院・診療所
• 診断検査室
• 製薬・バイオテクノロジー企業
• 学術研究機関
• 公衆衛生機関

世界の抗菌薬耐性サーベイランスの市場規模・CAGR (2025～2032年)

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング (2024年)
• 主要企業が採用した戦略
• 市場の近年の動向
• 主要企業の市場シェア (2024年)
• 主要企業のプロファイル
  • 企業概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較 (2022～2024年)

主要企業プロファイル

• bioMerieux SA（フランス）
• Thermo Fisher Scientific Inc.（米国）
• BD（米国）
• Roche Diagnostics（スイス）
• OpGen Inc.（米国）
• Luminex Corporation（米国）
• Accelerate Diagnostics Inc.（米国）
• Merck KGaA（ドイツ）
• Danaher Corporation（米国）
• Bruker Corporation（米国）
• QuantuMDx Group Ltd.（英国）
• ArcBio LLC（米国）
• Bugworks Research Inc.（インド）

結論と提言

Global Antimicrobial Resistance Surveillance Market size was valued at USD 5.9 billion in 2023 and is poised to grow from USD 6.23 billion in 2024 to USD 9.63 billion by 2032, growing at a CAGR of 5.6% during the forecast period (2025-2032).

The escalating prevalence of antimicrobial resistance poses significant global health challenges, prompting heightened attention from governments, health organizations, and international bodies toward robust surveillance systems. The necessity for swift data collection, pathogen tracking, and resistance pattern assessment is surging in response to increasing drug-resistant infections, emphasizing the demand for advanced antimicrobial resistance surveillance capabilities that facilitate quick detection and informed clinical choices. This intensified focus on public health readiness and infection management is catalyzing market expansion. Concurrently, regulatory initiatives and global action frameworks are pressuring enhancements in surveillance capabilities. Nations are investing in laboratory infrastructure and integrated data systems for real-time reporting, thereby bolstering surveying efficiency. Healthcare providers leverage these systems to enhance infection control, emphasizing antimicrobial stewardship and reducing healthcare-associated infections, ultimately supporting accelerated market development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antimicrobial Resistance Surveillance market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Antimicrobial Resistance Surveillance Market Segments Analysis

Global Antimicrobial Resistance Surveillance Market is segmented by Component, Technology, End User and region. Based on Component, the market is segmented into Software, Hardware and Services. Based on Technology, the market is segmented into Phenotypic Methods, Genotypic Methods and Bioinformatics Solutions. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes and Public Health Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Antimicrobial Resistance Surveillance Market

The growing prevalence of drug-resistant infections is now a significant public health concern, prompting urgent attention from health authorities worldwide. As resistance rates escalate, there is a pressing need for advanced surveillance systems that can monitor resistance patterns in real time, enabling timely interventions. Both national and local governments recognize the critical importance of enhancing antimicrobial resistance surveillance to effectively manage outbreaks, mitigate treatment failures, and inform public health policies. This collective effort to address the escalating issue of antimicrobial resistance has notably driven the expansion of the global antimicrobial resistance surveillance market, reflecting a commitment to safeguarding public health.

Restraints in the Global Antimicrobial Resistance Surveillance Market

The development of an effective antimicrobial resistance surveillance system faces considerable challenges, primarily due to the substantial financial investment needed for laboratory infrastructure, data integration technologies, and skilled workforce training. These constraints are especially pronounced in lower-income nations, where resources are often limited. Furthermore, the considerable expenses involved in analyzing surveillance data through genomic methods hinder the market's expansion and accessibility on a global scale. This combination of financial and operational hurdles poses significant obstacles that can impede the establishment and functionality of comprehensive surveillance systems crucial for combating antimicrobial resistance worldwide.

Market Trends of the Global Antimicrobial Resistance Surveillance Market

The global antimicrobial resistance surveillance market is witnessing a notable trend characterized by the integration of artificial intelligence with genomic surveillance techniques. This fusion enhances the effectiveness of monitoring efforts by utilizing AI-based platforms in conjunction with whole-genome sequencing and advanced bioinformatics tools. Such innovation enables the precise identification of resistance genes, timely outbreak alerts, and refined predictive modeling. Consequently, healthcare systems are empowered to bolster their surveillance capabilities, thereby improving response strategies and mitigating the spread of antimicrobial resistance. This shift towards technological advancements signifies a proactive approach to tackling one of the most pressing challenges in global health.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Antimicrobial Resistance Surveillance Market Size by Component & CAGR (2025-2032)

• Market Overview
• Software
• Hardware
• Services

Global Antimicrobial Resistance Surveillance Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Phenotypic Methods
• Genotypic Methods
• Bioinformatics Solutions

Global Antimicrobial Resistance Surveillance Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Public Health Agencies

Global Antimicrobial Resistance Surveillance Market Size & CAGR (2025-2032)

• North America (Component, Technology, End User)
  • US
  • Canada
• Europe (Component, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpGen Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accelerate Diagnostics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuantuMDx Group Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArcBio LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bugworks Research Inc. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations